XENE
Xenon Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$39.75
−30.69%Next report
Analyst consensus
- Next report date
- Nov 2, 2026
- EPS estimate
- -$1.17
- Revenue estimate
- $1.3M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$1.11
- EPS estimate
- -$1.14
- Revenue actual
- —
- Revenue estimate
- $1.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +1.0%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $64
- PT range
- $46 – $90
- Analysts
- 6
5 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$1.14 | -$1.11 | Beat 2.63% | — |
| May 7, 2026 | -$1.17 | -$1.17 | In line | — |
| Feb 27, 2025 | -$0.89 | -$0.84 | Beat 5.62% | — |
| Aug 8, 2024 | -$0.72 | -$0.75 | Miss -4.17% | — |
| May 9, 2024 | -$0.69 | -$0.62 | Beat 10.14% | — |
| Feb 29, 2024 | -$0.76 | -$0.64 | Beat 15.79% | $5.4M |
| Mar 1, 2023 | -$0.58 | -$0.57 | Beat 1.72% | — |
| Mar 1, 2022 | -$0.47 | -$0.57 | Miss -21.28% | $3.7M |
| Nov 10, 2021 | -$0.44 | -$0.36 | Beat 18.18% | $8.1M |
| Aug 11, 2021 | -$0.49 | -$0.51 | Miss -4.08% | $2.2M |
| Mar 1, 2021 | -$0.40 | -$0.34 | Beat 15.00% | $5.2M |
| Nov 5, 2020 | -$0.15 | -$0.25 | Miss -66.67% | $6.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 2, 2026